Implementation of medication alert systems and pharmacist satisfaction: a questionnaire-based study [0.03%]
基于问卷调查的药物警戒系统实施及其药师满意度研究
Takashi Omoto,Manato Inagaki,Junichi Asaka et al.
Takashi Omoto et al.
Background: As a component of clinical decision support systems, medication alert systems (MAS) play an important role in preventing medication errors. However, their effectiveness is often limited by alert fatigue. Compr...
Correction: Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study [0.03%]
订正：奥比妥珠单抗输注相关反应发生率与预防用药糖皮质激素剂量的多中心回顾性队列研究关联性分析校正意见
Tatsuya Ohtsubo,Kazuhiro Yamamoto,Saori Matumoto et al.
Tatsuya Ohtsubo et al.
Early-onset duodenal perforation during bevacizumab-containing chemotherapy in a patient with ovarian cancer: a case report [0.03%]
早发性肠道穿孔并发毕克莫单抗治疗卵巢癌的病例报告
Satoshi Nagase,Keisuke Taguchi,Takanori Yoshida et al.
Satoshi Nagase et al.
Background: Bevacizumab-induced gastrointestinal perforation is a potentially fatal adverse event. However, duodenal perforations are rare. Conversely, patients with cancer often have concomitant rheumatoid arthritis and ...
An eight-year national follow-up study on the employment trajectories of early-career pharmacists in Japan up to 2020 [0.03%]
日本药学毕业生就业轨迹的全国性8年随访研究（截至2020年）
Takahito Ando,Takeru Shiroiwa,Shinobu Imai et al.
Takahito Ando et al.
Background: Geographic and sectoral maldistribution of pharmacists has become a critical challenge for Japan's healthcare system. While the number of community pharmacists continues to rise, the chronic shortage of hospit...
Validity and reliability evaluation of the Functional Assertiveness Scale for community pharmacists: a cross-sectional study [0.03%]
社区药剂师功能性主动性量表的有效性和可靠性评价：横断面研究
Mitsuaki Ishii,Sachiko Ozone,Shoichi Masumoto et al.
Mitsuaki Ishii et al.
Background: Interprofessional collaboration between physicians and pharmacists is important for ensuring medication safety. Community pharmacists play a vital role in this process through prescription recommendations to p...
Markedly elevated blood concentrations of everolimus during concomitant posaconazole therapy in a liver transplant recipient: a case report [0.03%]
肝移植受者同时使用泊沙康唑治疗期间的依维莫司血液浓度显著升高：病例报告
Machiko Hirai,Keisuke Umemura,Yoshiki Katada et al.
Machiko Hirai et al.
Background: Everolimus (EVL) is widely used as an immunosuppressive agent in combination with calcineurin inhibitors, including tacrolimus (TAC), after liver transplantation. Posaconazole (PSCZ) is a triazole antifungal a...
Syndrome of inappropriate antidiuretic hormone secretion following immune effector cell-associated neurotoxicity syndrome during blinatumomab therapy: a case report [0.03%]
免疫效应细胞相关神经毒性综合征期间出现抗利尿激素不适当分泌综合症的病例报告——布林沙珠单抗治疗过程中发生的罕见神经系统不良事件
Misato Yoshihara,Satoshi Yuyama,Osamu Yasumuro et al.
Misato Yoshihara et al.
Background: Blinatumomab (BLINA) causes immune-related toxicities, such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome (ICANS). Although hyponatremia associated with interleukin (I...
Assessment of community pharmacists' knowledge, attitudes, awareness, and practice-related responses regarding oral anticoagulants in the Northern West Bank, Palestine: a cross-sectional study [0.03%]
关于巴勒斯坦北约旦河西岸地区社区药剂师对口服抗凝血剂知识、态度、意识和实践相关反应的横断面研究评估
Hanan M Alayyad,Saja W Abu Arqoub,Malak A Abuobaid et al.
Hanan M Alayyad et al.
Background: Oral anticoagulants, including warfarin and direct oral anticoagulants (DOACs), are widely used for the prevention and treatment of thromboembolic disorders. Community pharmacists are accessible healthcare pro...
Serum KL-6 and eGFR predict everolimus-associated KL-6 elevation in heart transplant recipients: a retrospective observational study [0.03%]
血清KL-6和eGFR可预测他克莫司相关的心脏移植受者的KL-6升高：一项回顾性观察研究
Yuhei Suzuki,Toyohito Oriyama,Takehito Yamamoto et al.
Yuhei Suzuki et al.
Background: Everolimus (EVR), which is widely used in heart transplant recipients, has been associated with drug-induced lung injury. Although EVR-associated lung injury has been reported in patients with malignancies and...
Risk modifiers of immune-related adverse events in patients with NSCLC undergoing immunotherapy: a retrospective cohort study [0.03%]
免疫治疗过程中影响非小细胞肺癌患者发生免疫相关不良事件的风险因素：一项回顾性队列研究
Takashi Watanabe,Naoto Suzuki,Masahito Yamauchi et al.
Takashi Watanabe et al.
Background: To investigate immune-related adverse events (irAEs) in patients with non-small cell lung cancer receiving immune checkpoint inhibitor (ICI) therapy, and to identify clinical factors associated with irAE onset...